RT Journal Article
SR Electronic
T1 A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.24.20042119
DO 10.1101/2020.03.24.20042119
A1 Ying Zhou
A1 Zhen Yang
A1 Yanan Guo
A1 Shuang Geng
A1 Shan Gao
A1 Shenglan Ye
A1 Yi Hu
A1 Yafei Wang
YR 2020
UL http://medrxiv.org/content/early/2020/03/27/2020.03.24.20042119.abstract
AB Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, Hubei, China. This study sought to elucidate a novel predictor of disease severity in patients with coronavirus disease-19 (COVID-19) cased by SARS-CoV-2.Methods Patients enrolled in this study were all hospitalized with COVID-19 in the Central Hospital of Wuhan, China. Clinical features, chronic comorbidities, demographic data, and laboratory and radiological data were reviewed. The outcomes of patients with severe pneumonia and those with non-severe pneumonia were compared using the Statistical Package for the Social Sciences (IBM Corp., Armonk, NY, USA) to explore clinical characteristics and risk factors. The receiver operating characteristic curve was used to screen optimal predictors from the risk factors and the predictive power was verified by internal validation.Results A total of 377 patients diagnosed with COVID-19 were enrolled in this study, including 117 with severe pneumonia and 260 with non-severe pneumonia. The independent risk factors for severe pneumonia were age [odds ratio (OR): 1.059, 95% confidence interval (CI): 1.036–1.082; p < 0.001], N/L (OR: 1.322, 95% CI: 1.180–1.481; p < 0.001), CRP (OR: 1.231, 95% CI: 1.129–1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013–1.107; p = 0.011). We identified a product of N/L*CRP*D-dimer as having an important predictive value for the severity of COVID-19. The cutoff value was 5.32. The negative predictive value of less than 5.32 for the N/L*CRP*D-dimer was 93.75%, while the positive predictive value was 46.03% in the test sets. The sensitivity and specificity were 89.47% and 67.42%. In the training sets, the negative and positive predictive values were 93.80% and 41.32%, respectively, with a specificity of 70.76% and a sensitivity of 89.87%.Conclusions A product of N/L*CRP*D-dimer may be an important predictor of disease severity in patients with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors have had no support to declare related to the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data during the study are available in a repository or online.ALBserum albuminALTalanine transaminaseARDSacute respiratory distress syndromeASTaspartate aminotransferaseAUCarea under the receiver operating characteristic curveBUNblood urea nitrogenCOVID-19coronavirus disease-19Crserum creatinineCHDcoronary heart diseaseCRPC-reactive proteinCTcomputed tomographyHBPhigh blood pressureLlymphocyteNneutrophilN/Lratio of neutrophils to lymphocytesN/L*CRP*D-dimerproduct of N/L, CRP, and D-dimerROCreceiver operating characteristicSARSsevere acute respiratory syndromeSARS-CoV-2severe acute respiratory syndrome (SARS) coronavirus 2T2DMtype 2 diabetes mellitusWBCwhite blood cell